A retrospective study to evaluate the occurrence of punctate pattern (PP) for diagnosis of progressive multifocal leukoencephalopathy (PML) related to natalizumab or not in patients with relapse remitting multiple sclerosis

Trial Profile

A retrospective study to evaluate the occurrence of punctate pattern (PP) for diagnosis of progressive multifocal leukoencephalopathy (PML) related to natalizumab or not in patients with relapse remitting multiple sclerosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2016

At a glance

  • Drugs Natalizumab (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 01 Apr 2016 New trial record
    • 23 Mar 2016 Results published in the Neurology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top